Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2018.01035 Immunology Original Research Impaired Immune Response to Primary but Not to Booster Vaccination Against Hepatitis B in Older Adults Weinberger Birgit 1 * Haks Mariëlle C. 2 de Paus Roelof A. 2 Ottenhoff Tom H. M. 2 Bauer Tanja 3 Grubeck-Loebenstein Beatrix 1 1Institute for Biomedical Aging Research, Universität Innsbruck, Innsbruck, Austria 2Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands 3Institute of Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany

Edited by: Peter Andersen, State Serum Institute (SSI), Denmark

Reviewed by: Anita S. Iyer, Harvard Medical School, United States; Sarah Rowland-Jones, University of Oxford, United Kingdom

*Correspondence: Birgit Weinberger, birgit.weinberger@uibk.ac.at

These authors have contributed equally to this work.

Specialty section: This article was submitted to Vaccines and Molecular Therapeutics, a section of the journal Frontiers in Immunology

15 05 2018 2018 9 1035 13 12 2017 25 04 2018 Copyright © 2018 Weinberger, Haks, de Paus, Ottenhoff, Bauer and Grubeck-Loebenstein. 2018 Weinberger, Haks, de Paus, Ottenhoff, Bauer and Grubeck-Loebenstein

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Many current vaccines are less immunogenic and less effective in elderly compared to younger adults due to age-related changes of the immune system. Most vaccines utilized in the elderly contain antigens, which the target population has had previous contact with due to previous vaccination or infection. Therefore, most studies investigating vaccine-induced immune responses in the elderly do not analyze responses to neo-antigens but rather booster responses. However, age-related differences in the immune response could differentially affect primary versus recall responses. We therefore investigated the impact of age on primary and recall antibody responses following hepatitis B vaccination in young and older adults. Focused gene expression profiling was performed before and 1 day after the vaccination in order to identify gene signatures predicting antibody responses. Young (20–40 years; n = 24) and elderly (>60 years; n = 17) healthy volunteers received either a primary series (no prior vaccination) or a single booster shot (documented primary vaccination more than 10 years ago). Antibody titers were determined at days 0, 7, and 28, as well as 6 months after the vaccination. After primary vaccination, antibody responses were lower and delayed in the elderly compared to young adults. Non-responders after the three-dose primary series were only observed in the elderly group. Maximum antibody concentrations after booster vaccination were similar in both age groups. Focused gene expression profiling identified 29 transcripts that correlated with age at baseline and clustered in a network centered around type I interferons and pro-inflammatory cytokines. In addition, smaller 8- and 6-gene signatures were identified at baseline that associated with vaccine responsiveness during primary and booster vaccination, respectively. When evaluating the kinetic changes in gene expression profiles before and after primary vaccination, a 33-gene signature, dominated by IFN-signaling, pro-inflammatory cytokines, inflammasome components, and immune cell subset markers, was uncovered that was associated with vaccine responsiveness. By contrast, no such transcripts were identified during booster vaccination. Our results document that primary differs from booster vaccination in old age, in regard to antibody responses as well as at the level of gene signatures.

Clinical Trial Registration

www.clinicaltrialsregister.eu, this trial was registered at the EU Clinical Trial Register (EU-CTR) with the EUDRACT-Nr. 2013-002589-38.

hepatitis B virus vaccine primary vaccination booster vaccination elderly gene expression profiling 280873 Seventh Framework Programme10.13039/100011102

香京julia种子在线播放

    1. <form id=HxFbUHhlv><nobr id=HxFbUHhlv></nobr></form>
      <address id=HxFbUHhlv><nobr id=HxFbUHhlv><nobr id=HxFbUHhlv></nobr></nobr></address>

      Introduction

      Life expectancy is increasing worldwide, and the number of persons older than 60 years of age is expected to double, reaching 2.1 billion by 2050 (1). The incidence and severity of many infectious diseases is high in the elderly compared to that in younger adults (2). Vaccination is one of the most effective measures to prevent infections, but most current vaccines are less immunogenic and less efficient in older adults. Age-related changes of the immune system include a decline of naïve T and B cells (3, 4), which potentially hampers immune responses to neo-antigens. It has been shown that primary immune responses to vaccines against tick-borne encephalitis (5), Japanese encephalitis (6), hepatitis A (7), and pandemic influenza strains (8) are lower in the elderly. Reduced immunogenicity in old age has also been shown for booster vaccinations against tetanus, diphtheria (9,  10), and tick-borne encephalitis (11). However, the molecular mechanisms underlying age-related hyporesponsiveness to vaccination remain unclear. Genome-wide RNA expression profiling has identified a clear association between chronological age and progressive changes in the transcriptional landscape of peripheral blood cells. Significant age-related changes were found in the transcript levels of markers involved in, e.g., immunosenescence, inflammation, and oxidative stress (12). Moreover, many of the identified genes were highly and preferentially expressed in naïve and memory T and B cells and may thus reflect age-related changes in immune function (13, 14). Hence, pre-immunization transcriptomic profiles and/or changes in gene expression patterns in blood, resulting from the elicited innate and adaptive immune responses after vaccination, could potentially be used as biomarkers to classify and predict vaccine responsiveness and be key to a better understanding of (hypo)responsiveness to vaccination in the elderly population.

      Immune responses after influenza and pneumococcal vaccination—the most studied vaccines in the elderly—are usually a mixture of primary and recall responses, as natural contact with various influenza strains and pneumococcal serotypes is frequent, but vaccines might also contain neo-antigens. It is therefore rare that primary responses and purely vaccine-induced recall responses (without natural exposure) to the same antigens are investigated in the elderly. We have chosen hepatitis B virus surface antigen (HBsAg) as a model antigen since natural exposure to hepatitis B virus (HBV) is relatively rare in Austria (15), and primary as well as booster vaccinations can be performed in young and older adults following national recommendations.

      In addition to the value of HBsAg as a model antigen, HBV is also of clinical relevance for the older population. Acute infection with HBV is mainly recognized in young adults with high-risk behaviors, but is also relevant in old age (16). Older adults with viral hepatitis have a higher mortality rate than younger patients, which can be partially explained by underlying comorbidities, but also by a diminished immune response, metabolic and nutritional deficiencies, and age-related anatomic changes of the liver (1719). Progression of acute HBV infection to chronicity occurs in less than 5% of young adults, but is observed more frequently in the elderly. In an outbreak in a nursing home in Japan, almost 60% of the infected elderly became HBsAg carriers (20). The prevalence of HBsAg (>6 months), which indicates chronic infection, is higher in nursing home residents compared with non-institutionalized populations, and the risk of transmission is higher in these facilities (21).

      Childhood vaccination against hepatitis B is recommended in many countries. Most European countries and the USA also recommend primary vaccination of adults and booster vaccinations for persons with an increased risk for infection. In addition to persons with high-risk lifestyles (use of injected drugs, high-risk sexual behavior) or occupational risk factors (e.g., health-care personnel, police and other emergency service personnel, persons working with refugees), these risk groups include household contacts of chronically infected patients, patients with chronic liver disease, persons undergoing dialysis or regularly receiving plasma products, and persons under immunosuppressive therapy. All of these risk groups are also composed of older persons (2227). In addition, vaccination is recommended for persons traveling to areas with a high prevalence of chronic HBV infection. Due to increased life expectancy as well as improved health status and mobility of elderly persons, the number of older long-distance travelers rises. The exact data on the extent of travel by older adults are limited, but data from several countries indicate that a substantial fraction of long-distance travelers are over the age of 65 (28, 29). Primary immunization against hepatitis B is performed relatively late in life, e.g., in travelers, household contacts of chronic hepatitis B carriers, or persons at risk in long-term care facilities. For this reason, the goal of this study was to compare the outcome of primary versus booster vaccination against hepatitis B in young and elderly persons from the same geographical and social background at the level of antibody response and gene signatures.

      Materials and Methods Study Cohort

      Two study cohorts of young and old healthy adults were recruited. Group A had never been vaccinated against hepatitis B and received a primary immunization series (three doses, 0–1–6 months). Serum was collected at days 0, 7, and 28 after each vaccination as well as 6 months after the last dose. Group B comprised persons who had received a full primary vaccination against hepatitis B at least 10 years ago and now received a single booster vaccination. Serum was collected at days 0, 7 and 28, and 6 months after the vaccination. Whole blood was collected in PAXgene blood RNA tubes (PreAnalytiX GmbH, Switzerland) before and 1 day after the first vaccination for expression analysis. Each group included young and old donors (Table 1). Persons with chronic viral infection (human immunodeficiency virus, hepatitis B virus, hepatitis C virus), transplant recipients, and patients under immunosuppressive or chemotherapy were not included in the study. Twinrix® (Glaxo Smith Kline, UK), which contains 720 ELISA units of inactivated hepatitis A virus and 20-µg recombinant HBsAg adjuvanted with Al(OH)3 and AlPO4, was used for all vaccinations. The objective of this study was to measure the hepatitis B-specific immune response. The protocol was approved by the ethics committee of the Innsbruck Medical University. All participants gave their written informed consent in accordance with the Declaration of Helsinki. This trial was registered at the EU Clinical Trial Register (EU-CTR) with the EUDRACT-Nr. 2013-002589-38.

      Characteristics of study cohort.

      n Median age (years) Age range (years) Cytomegalovirus seropositive
      Group A Young 12a 27.5 20–40 27%c
      Old 9b 72 60–84 67%

      Group B Young 12 29.5 20–38 58%
      Old 8 68.5 62–74 50%

      aOne person was excluded from the analysis because HBsAg-specific antibodies were detectable at day 0 indicating previous contact with HBV.

      bTwo persons were excluded from the analysis because HBsAg-specific antibodies were detectable at day 0 indicating previous contact with HBV.

      cCMV serology was not available for one person.

      Detection of HBsAg-Specific and Cytomegalovirus (CMV)-Specific Antibodies

      Serum levels of HBsAg-specific antibodies (anti-HBs) were quantified using the ARCHITECT® chemiluminescence microparticle immunoassay (Abbott Diagnostics, Wiesbaden, Germany). Samples with anti-HBs levels below the limit of detection (0.9 IU/l) were set to 0.45 IU/l and samples with antibody levels above the dynamic range of the assay (10,000 IU/l) were diluted and re-tested. Serum levels of CMV-specific antibodies were quantified by ELISA using the Serion ELISA classic CMVs IgG Kit (Virion/Serion GmbH, Würzburg, Germany). Individuals with antibody concentrations below 25 PEI-U/ml are considered to be seronegative and values above 40 PEI-U/ml indicate seropositive individuals. Values between 25 and 40 PEI-U/ml are considered borderline, but were not seen in this study.

      RNA Isolation

      Total RNA from venipuncture PAXgene blood collection tubes was extracted using the PAXgene Blood mRNA kit (PreAnalytiX GmbH, Switzerland) according to the manufacturer’s protocol. The RNA yield was determined by a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA), while the quality and integrity of the RNA were assessed on an Agilent 2100 BioAnalyzer (Agilent Technologies, Amstelveen, The Netherlands) using the RNA 6000 Nano Chip kit. The average RNA integrity number of the total RNA samples obtained from PAXgene tubes was 9.6 ± 0.05.

      Dual-Color Reverse-Transcription Multiplex Ligation-Dependent Probe Amplification (dcRT-MLPA)

      Focused gene expression profiling using dcRT-MLPA was performed in triplicate as described in detail elsewhere (30). Briefly, for each target-specific sequence, a specific reverse transcription (RT) primer was designed located immediately downstream of the left- and right-hand half-probe target sequence. RNA was reverse transcribed using an RT-primer mix and MMLV reverse transcriptase (Promega Benelux, Leiden, The Netherlands). Transcriptase activity was inactivated by heating at 98°C for 2 min. Following RT, the left- and right-hand half-probes were hybridized to the cDNA at 60°C overnight. Annealed half-probes were ligated using ligase 65 and subsequently amplified by PCR (33 cycles of 30 s/95°C, 30 s/58°C, 60 s/72°C, followed by 1 cycle of 20 min/72°C). Primers and probes were from Sigma-Aldrich Chemie (Zwijndrecht, The Netherlands) and MLPA reagents from MRC-Holland (Amsterdam, The Netherlands). PCR amplification products were diluted 1:10 in HiDi-formamide containing 400HD ROX size standard, denatured at 95°C for 5 min, ice-cooled, and analyzed on an Applied Biosystems 3730 capillary sequencer in GeneScan mode (BaseClear, Leiden, The Netherlands).

      Reverse transcription primers and half-probes were designed by Leiden University Medical Center (Department of Infectious Diseases, Leiden, The Netherlands) (30) and comprised sequences for four housekeeping genes (including GAPDH) and 144 selected genes to profile innate, adaptive, and inflammatory immune responses (Table S1 in Supplementary Material).

      Trace data were analyzed using GeneMapper software 5 package (Applied Biosystems, Bleiswijk, The Netherlands). The areas of each assigned peak (in arbitrary units) were exported for further analysis in Microsoft Excel. Data were normalized to GAPDH, and signals below the threshold value for noise cutoff in GeneMapper (log2-transformed peak area of 7.64) were assigned the threshold value. Finally, the normalized data were log2-transformed for statistical analysis.

      RNA expression values were visualized by principal component analysis (PCA) plots and heatmaps using the hierarchical clustering algorithms of Clustvis.1 String network analysis2 or Ingenuity Pathway Analysis of genes that were differentially expressed was performed to identify relevant signaling pathways and regulatory networks.

      Statistical Analysis

      Statistical analyses of antibody concentrations for the two age groups were performed for each time point using the nonparametric Mann–Whitney U-test. Triplicate measurements of log2-transformed dcRT-MLPA-derived gene expression data were analyzed for statistical significance between two populations (young versus old adults or persons with ≥10,000 IU/l versus <10,000 IU/l anti-HBs) using the Mann–Whitney U-test. Statistical tests were two-sided, and p-values were adjusted for multiple testing using the Benjamini–Hochberg correction. Findings were regarded positive when meeting the criterion on the false discovery rate (FDR) of <10% and an optional factorial change (FC) of 1.25. Since relatively few samples were included in our study, leave-one-out cross-validation (LOOCV) was performed in the PCA analysis to estimate the generalization ability of the gene signatures as classifiers, and Wilks’ Lambda test was used to test for differences between groups. The chi-squared test was used to test the independence of the two categorical variables’ age and vaccine responsiveness. Significant differences were evaluated using the Fisher’s exact test. Statistical computation was performed using SPSS 23 software.

      Results Antibody Responses After Primary Vaccination

      Young and old healthy adult volunteers who had never received a hepatitis A or B vaccination were recruited to receive a primary vaccination series (months 0–1–6) with a combined hepatitis A/B vaccine. HBsAg-specific antibody concentrations were measured before, 1 week, and 4 weeks after each dose, as well as 6 months after the last dose. None of the old participants mounted antibody responses after the first dose of the vaccine, whereas low levels of HBsAg-specific IgG were detectable in 40% of the young group, 4 weeks after the first dose (range 5.70–18.75 IU/l). After the second dose, antibody concentrations increased in all but one of the young participants (median 28.8-fold, range 1.8–418.8), but only in two (29%) of the older vaccines (40.3- and 68.5-fold, respectively). As expected, a further increase in antibody concentrations was observed after the third vaccination in both the young (median 31.2-fold, range 12.2–6,052.6) and the old group (median 29.3-fold, range 1–268.2). The median drop of antibody concentrations was 2.8-fold (range 0.7–9.1) within the first 6 months after the last vaccination with no age-related differences (Mann–Whitney U-test; p = 0.833). Figure 1A depicts the geometric mean antibody concentrations for both age groups.

      HBsAg-specific antibody concentrations after primary vaccination series. Geometric mean concentrations and 95% confidence intervals of anti-HBs are depicted. Dashed vertical lines indicate the time points of vaccination (weeks 0–4–26). The limit of detection is 0.9 IU/l. Samples below this value were set to 0.45 IU/l. (A) This graph depicts data for young (blue; n = 11) and old (red; n = 7) participants. Mann–Whitney U-test young versus old; *p < 0.05; **p < 0.01. (B) This graph depicts data for young (blue; n = 11) participants, old responders (red; n = 5) and old non-responders (light red; n = 2). Mann–Whitney U-test young versus old responders; *p < 0.05.

      Two of the old participants (29%) did not develop detectable antibodies (<0.9 IU/l) at any time point following primary vaccination and were classified as non-responders (NRs), whereas antibody concentrations were above 100 IU/l for all young participants. Figure 1B depicts the geometric mean antibody concentrations for the young (same as in Figure 1A), as well as the old responders (R) and old NR separately. When only the old responders were considered, their antibody concentrations were still lower than in the young group. This difference was only significant at week 8, probably due to the relatively low sample size.

      Antibody Responses After Booster Vaccination

      Young and old healthy adults, who had received a complete primary series of hepatitis vaccination more than 10 years ago, received one dose of hepatitis A/B vaccine. Anti-HBs concentrations were measured before, 1 week, 4 weeks, and 6 months after the vaccination. Antibody concentrations before the booster vaccination ranged from below the limit of detection (<0.9 IU/l) to 3270 IU/l and were similar for both age groups (young versus old, p = 0.910, Mann–Whitney U-test). Within the first 4 weeks after vaccination, anti-HBs concentrations increased in young (median 469.4-fold, range 1–1,120.5) and old (median 328.1-fold, range 1–2,325.6) participants. No age-related differences were seen at any time point (young versus old, p = 0.678–1.000, Mann–Whitney U-test). The median decline of antibodies from weeks 4 to 26 was 4.4-fold (range 1.4–14.9). Figure 2A depicts the geometric mean antibody concentrations for all participants.

      HBsAg-specific antibody concentrations after booster vaccination. One booster dose of vaccine was administered at week 0 as indicated by the vertical dashed line. The limit of detection is 0.9 IU/l. Samples below this value were set to 0.45 IU/l. (A) Geometric mean concentrations and 95% confidence intervals of anti-HBs are depicted for young (blue; n = 12) and old (red; n = 8) participants. (B) Geometric mean concentrations and 95% confidence intervals of anti-HBs are depicted for young (dark blue; n = 8) participants with anti-HBs concentrations of ≥10 IU/l prior to the booster vaccination. Individual antibody concentrations are shown for four young (light blue) participants, with low (<10 IU/l) anti-HBs at the time of enrollment. The numbers in brackets represent the time since the last vaccination (years) for the individual donors. (C) Geometric mean concentrations and 95% confidence intervals of anti-HBs are depicted for old (dark red; n = 4) participants with anti-HBs concentrations of ≥10 IU/l prior to the booster vaccination. Individual antibody concentrations are shown for four old (light red) participants, with low (<10 IU/l) anti-HBs at the time of enrollment. The numbers in brackets represent the time since the last vaccination (years) for the individual donors.

      Anti-HBs concentrations were below 10 IU/l in four young (33%) and four old (50%) participants at the time of enrollment. In three of the four young individuals, no anti-HBs were detectable at all. Primary vaccination had been documented for all individuals, but anti-HBs concentrations after the primary series were not available. Figures 2B,C depict the antibody concentrations for these individuals and show the geometric mean titers for young and old participants with anti-HBs concentrations of ≥10 IU/l before the booster vaccination in comparison. Two of the young individuals (young-1 and young-2) did not develop adequate antibody concentrations after the single booster shot. The primary vaccination series of these persons was performed in early childhood and therefore dated back 30 and 33 years, respectively. By contrast, the other individuals with low anti-HBs concentrations before the vaccination (young-3, young-4, and old-1–4) showed an anamnestic response to the booster dose and reached sufficient antibody concentrations. Their last hepatitis B vaccination dated back 10–13 years. A strong correlation of anti-HBs concentrations before (w0) and after the booster vaccination (w4) was observed for young (rS = 0.875; p < 0.001) and old (rS = 0.786; p = 0.021) vaccines.

      Correlation Between Pre-Immunization Transcriptomic Profiles and Vaccine Response

      Before exploring whether pre-immunization gene expression levels correlated with different responses to the hepatitis B vaccine between young and old adults, we first investigated the impact of age on the pre-immunization transcriptomic profiles. Mann–Whitney U-test was used to identify transcripts differentially expressed between young and old participants, and p-values were adjusted with the Benjamini–Hochberg method to correct for multiple testing. Using an FDR of <10%, we identified 29 transcripts whose pre-immunization expression levels correlated with age. This signature strongly clustered in a network centered around type I interferons (IFNα and IFNβ) and pro-inflammatory cytokines (IL-12, GM-CSF, and type II interferons TNFα and IFNγ) and was able to generally separate young and old adults’ pre-immunization following hierarchical cluster analysis and PCA (Figure 3). Applying an FC cutoff of >1.25 reduced the 29-gene signature to a 10-gene signature with improved accuracy (LOOCV of 70%) and discriminatory power (p = 0.031) (Figure S1 in Supplementary Material). Our finding that pro-inflammatory pathways predominate in elderly persons is in agreement with the study by Fourati et al., where genome-wide RNA expression profiles were compared between 30 participants aged 25–40 years and 144 participants aged ≥65 in Canada, which validates the results observed in our smaller-sized cohort (31).

      Impact of age on pre-immunization transcriptomic profiles. (A) Ingenuity Pathway Analysis of the 29 genes that were differentially expressed between young and old adults using a false discovery rate (FDR) of <10% (indicated in blue symbols). Type I interferons and pro-inflammatory cytokines are highlighted in red. (B) The median-centered gene expression of the 29-gene signature is represented using a blue to yellow to red color scale. Rows and columns correspond to the genes and the profiled samples, respectively. The age groups are presented in colored squares above each sample. (C) PCA analysis of the gene expression profile of the 29-gene signature. Blue and red spheres represent young and old adults, respectively.

      To investigate whether pre-immunization gene expression profiles correlated with different responses to the hepatitis B vaccine, participants were categorized independently of age, but based on their anti-HBs concentrations 4 weeks after the third dose of the primary series (week 30) or 4 weeks after the booster vaccination. Individuals reaching anti-HBs concentrations of ≥10,000 IU/l were considered as high responders. Based on this criterion, five out of eight (62.5%) young adults were considered high responders during primary vaccination while the large majority of old adults [six out of seven (85.7%)] did not reach anti-HBs concentrations of ≥10,000 IU/l, suggesting a strong correlation between chronological age and lower vaccine responsiveness during primary vaccination (chi-squared test: p = 0.036). By contrast, 6 out of 12 (50.0%) young adults and 3 out of 8 (37.5%) old adults were considered high responders during booster vaccination (chi-squared test: p = 0.582), corroborating the observation that the increase in anti-HBs concentration was only significantly different between the age groups after primary vaccination, but not after booster vaccination (Figures 1 and 2).

      Subsequently, Mann–Whitney U-test was used to identify transcripts differentially expressed between individuals with anti-HBs concentrations below or above 10,000 IU/l independent of age, and p-values were adjusted with the Benjamini–Hochberg method to correct for multiple testing. Using an FDR of <10% and an FC of >1.25, we uncovered eight transcripts during primary vaccination and six transcripts during booster vaccination whose pre-immunization expression levels correlated with vaccine responsiveness (Figures 4A,C), and the identified gene signatures displayed an LOOCV accuracy of 81 and 72%, respectively (Figures 4B,D). In Figure 5, plots of the single genes encompassing the identified eight- and six-gene signatures are depicted. During primary vaccination, higher basal expression levels of CD8A, CD14, IFITM1/3, LYN, SEC14L1, and TNIP and lower basal transcriptomic levels of IL9 and TNF were associated with high anti-HBs concentrations (Figure 5A), while during booster vaccination, increased basal expression levels of BLR1, CCR7, CD19, CD274, CTLA4, and IL6 were correlated with higher anti-HBs concentrations (Figure 5B). Since BLR1, CCR7, CD19, CD274, and CTLA4 are all transcripts highly and preferentially expressed on T cells and/or B cells, these data suggest that during booster vaccination, vaccine responsiveness is mainly determined by differences in the representation and/or function of peripheral blood lymphocytes.

      Correlation between pre-immunization transcriptomic profiles and vaccine responsiveness. (A,C) The median-centered gene expression of the transcripts whose pre-immunization expression levels correlated with vaccine responsiveness independent of age is represented using a blue to yellow to red color scale. Rows and columns correspond to the genes and the profiled samples, respectively. The vaccine responder groups are presented in colored squares above each sample. (A) It depicts the eight-gene signature identified after primary vaccination and (C) the six-gene signature identified after booster vaccination, respectively. (B,D) PCA analysis of the gene expression profile of the eight-gene signature identified during primary vaccination (B) and the six-gene signature identified during booster vaccination (D). Blue and red spheres represent individuals with anti-HBs concentrations of <10,000 and ≥10,000 IU/l, respectively.

      Correlation between pre-immunization expression levels of single genes and vaccine responsiveness. Correlation between pre-immunization expression levels of single genes (log2-transformed) and anti-HBs concentrations (log10-transformed) at week 30 following primary vaccination (A) or week 4 after booster vaccination (B) independent of age. Mann–Whitney U-test was used to identify transcripts differentially expressed between individuals with anti-HBs concentrationsof ≥10,000 or <10,000 IU/l independent of age, and p-values were adjusted using the Benjamini–Hochberg method to correct for multiple testing. The horizontal line indicates an anti-HBs concentration of 10,000 IU/l, which was used as a cutoff value to categorize participants. The vertical lines represent the median gene expression levels of the individuals with anti-HBs concentrations of <10,000 IU/l (<) and ≥10,000 IU/l (≥), and the area in between is indicated in gray. In case basal gene expression levels are significantly increased in high responders compared to persons with anti-HBs concentrations of <10,000 IU/l, the blue shading indicates the area above the median gene expression of the high responders and above an anti-HBs concentration of 10,000 IU/l. The area below the median gene expression levels of the persons with anti-HBs concentrations of <10,000 IU/l and below the anti-HBs concentration of 10,000 IU/l is shown in red. By contrast, if basal gene expression levels are significantly decreased in high responders compared to persons with anti-HBs concentrations of <10,000 IU/l, the opposite areas of the vertical lines representing the median gene expression levels are tinted using a similar color coding. Blue and red spheres represent young and old adults, respectively.

      Correlation Between the Kinetic Changes in Gene Expression Profiles and HBsAg-Specific Antibody Responses During Vaccination

      Before exploring whether FCs in gene expression profiles before and after vaccination correlated with distinct responses to the hepatitis vaccine between young and old adults, we first investigated the impact of age on the FCs of the transcriptomic profiles between d0 and d1 during primary and booster vaccination. Using an FDR of <10%, we identified 16 and 11 transcripts during the primary and booster vaccination, respectively, that correlated with age and displayed an FC of >1.25 (Figure 6). While inflammasome markers, IFN-inducible genes, and genes encoding pro-inflammatory cytokines dominated the 16-gene signature that discriminated young and old adults during primary vaccination, the 11-gene signature that distinguished young and old adults during booster vaccination primarily encompassed genes coding pattern recognition receptors, immune cell subset markers as well as IFN-inducible genes. The capacity of the 16- and 11-gene signature to separate young and old adults is depicted by PCA analysis in Figure 6.

      Impact of age on factorial changes (FCs) in transcriptomic profiles following primary or booster vaccination. FCs of transcriptomic profiles between d0 and d1 were calculated. Using an FDR of <10%, 16 and 11 transcripts were identified during the primary (A) and booster (B) vaccination, which correlated with age and displayed an FC of >1.25. (Top panels) The median-centered gene expression of differentially expressed genes is represented using a blue to yellow to red color scale. Rows and columns correspond to the genes and the profiled samples, respectively. The age groups are presented in colored squares above each sample. (Bottom panels) PCA analysis of the corresponding gene expression profiles. Blue and red spheres represent young and old adults, respectively.

      Next, to investigate whether FC in gene expression profiles before and after vaccination correlated with different responses to the hepatitis B vaccine, participants were again categorized into high responders (anti-HBs of ≥10,000 IU/l) and individuals not reaching these antibody levels, independent of age. FCs of transcriptomic profiles between d0 and d1 were calculated, and Mann–Whitney U-test was used to identify transcripts that were differentially regulated between the two groups independent of age. P-values were adjusted with the Benjamini–Hochberg method to correct for multiple testing. Using an FDR of <10% and an FC of >1.25, we uncovered 33 transcripts during primary vaccination that displayed an association with anti-HBs concentrations with excellent classifying capacity (Figures 7A,B). String network analysis revealed a network dominated by IFN-inducible genes, pro-inflammatory cytokines, inflammasome components, and immune cell subset markers (Figure 7C). In Figure 7D, plots of eight single genes that are part of the 33-gene signature are depicted, whose change in expression levels after vaccination not only correlated with anti-HBs concentrations after primary vaccination but also showed a significant correlation with chronological age (Mann–Whitney U-test: CD14  p < 0.001; NLRP1 p = 0.021; NLRP12 p = 0.042; RAB33A p = 0.044; TGFB1 p < 0.001; TNFRSF1A p < 0.001; TNFRSF1B p < 0.001; and TNIP1 p = 0.021). By contrast, none of the 144 transcripts displayed an association with anti-HB concentrations following booster vaccination. This finding is in concordance with the observation that the increase (fold-change) of anti-HBs concentrations after the booster vaccination (weeks 0–4) did not differ between high responders and individuals with anti-HBs of <10,000 IU/ml at week 4 (median 469.4-fold, range 72.5–743.8 versus median 467.1-fold, range 51.4–2325.6; p = 0.863, Mann–Whitney U-test). For this calculation, the two NRs were excluded.

      Correlation between factorial changes (FCs) of transcriptomic profiles following primary vaccination and vaccine responsiveness. FCs of transcriptomic profiles between d0 and d1 were calculated following primary vaccination independent of age. Mann–Whitney U-test was used to identify transcripts that were differentially regulated between individuals with anti-HBs concentrations of ≥10,000 and <10,000 IU/l independent of age, and p-values were adjusted with the Benjamini–Hochberg method to correct for multiple testing. Using an FDR of <10% and an FC of >1.25, 33 transcripts were found to be differentially expressed between the two groups. (A) The median-centered gene expression of the 33-gene signature is represented using a blue to yellow to red color scale. Rows and columns correspond to the genes and the profiled samples, respectively. The vaccine responder groups are presented in colored squares above each sample. (B) PCA analysis of the gene expression profile of the 33-gene signature. Blue and red spheres represent individuals with anti-HBs concentrations of <10,000 and ≥10,000 IU/l, respectively. (C) String network analysis of the proteins represented in the 33-gene signature. Individual proteins are displayed as nodes. Lines represent protein–protein interactions, and the thickness of the lines indicates confidence. (D) Plots of the eight single genes that showed both a correlation between FCs of transcriptomic expression levels before and after vaccination (d0 and d1) (log2-transformed) and anti-HBs concentrations at week 30 (log10-transformed) following primary vaccination (4 weeks after the third dose) as well as a correlation with age. The horizontal line indicates an anti-HBs concentration of 10,000 IU/l used as a cutoff value to categorize participants, and the area above the cutoff value (>10,000 IU/l) is highlighted in gray. Blue and red spheres represent young and old adults, respectively.

      Discussion

      In most cases, older adults are not immunologically naïve regarding the vaccines they receive. The most frequently studied vaccines in the elderly are against influenza and pneumococcal disease. Natural exposure to various influenza strains and pneumococcal serotypes induces immunological memory; therefore, even the first vaccination against those pathogens does not trigger a pure primary immune response. Primary, as well as booster immune responses against various pathogens, has been studied in the elderly (511), but a direct comparison using the same antigen is rarely done. We used HBsAg as a model antigen to investigate the impact of age on primary and booster immune responses following immunization in the absence of natural exposure.

      Blood samples were taken at several time points after each dose of vaccine in order to evaluate not only the maximal response but also the development of antibody concentrations over time. Despite small sample sizes, which are a limitation of this study, we could observe a number of age-related differences in the response to primary hepatitis B vaccination. Firstly, the antibody response to primary vaccination was delayed in the older group compared to that in the younger adults. No antibody responses were detectable in the older vaccines after the first vaccination, and only 30% of the older participants showed an increase in antibodies after the second dose. By contrast, all but one young participant had mounted protective antibody levels 4 weeks after the second dose. In order to achieve protection, three doses of vaccine are needed for the elderly. This finding is of particular relevance when hepatitis B vaccine is administered as a travel vaccine, as usually only two doses of vaccine are administered before the travel activity. An age-associated delay in primary immune responses has also been described for yellow fever vaccine, with only 50% seroprotection in the older compared to 77% in the younger age group at day 10 after vaccination (32). Age has been reported to be a risk factor for being an NR to HBV vaccination in individual studies (3336), as well as in meta-analyses (37, 38). In concordance with these studies, we observed NRs in the old, but not in the young age group. It has been shown previously that only 34% of an old and potentially frail (median age 72 years, range 57–95) cohort in a long-term care facility developed anti-HBs concentrations of >10 IU/ml after three doses of hepatitis B vaccination (39). The decline of antibody concentrations over time (weeks 30–52) was similar for both age groups.

      By contrast, both young and older adults respond similarly to booster vaccination against HBV, and the decline of antibodies over 6 months did not show age-related differences. We have previously reported that recall responses to other vaccine antigens are lower in the elderly compared to younger adults (9, 11), but this was not the case in the current study. A prerequisite for successful booster vaccination is adequate priming. It can be speculated that primary vaccination (e.g., against tetanus and diphtheria), which is administered in early childhood, might not have been complete for all older adults contributing to low responses to booster vaccination in old age. All participants of the current study had completed a three-dose primary series at least 10 years prior to enrollment and at least for the older cohort, primary vaccination had been administered during adulthood. Studies indicate that immunological memory remains intact for at least 20 years among healthy vaccinated individuals who initiated hepatitis B vaccination >6 months of age (40). Even after the loss of anti-HBs, T cells may still confer protection (41). In a long-term follow-up of two clinical trials performed in the early 1990s, almost all participants still had detectable anti-HBs 20 years after primary vaccination (42). It has been reported that approximately 20% of health-care workers did not possess detectable HBsAg-specific antibodies more than 10 years after the primary vaccination. Booster vaccination led to an increase of antibody concentrations in almost all participants (43). Notably, all participants of these two studies received the primary vaccination series as adults. Primary vaccination of adolescents (12–15 years) resulted in 80% of the vaccines retaining specific antibodies 15 years later. Upon booster vaccination of 19 individuals without residual antibodies, all but one mounted a robust anamnestic response (44). By contrast, several studies showed that only 20–30% of adolescents who received primary vaccination in infancy still had protective anti-HBs levels around age 18 (4547). The age when primary vaccination is received appears to play an important role in the long-term maintenance of anti-HBs. Among vaccinated cohorts who initiated hepatitis B vaccination at birth, long-term follow-up studies are ongoing to determine the duration of vaccine-induced immunity (40). Leuridan and Van Damme have summarized several studies from different countries in which booster vaccination was administered to individuals who had received primary vaccination in infancy, but had antibody concentrations below 10 IU/l several years later. Anamnestic responses to the booster vaccination were less frequent with increasing time since the primary vaccination and ranged from 100%, 5 years after the primary vaccination to 75.6% after 18–23 years (48). In our small cohort, two young participants had received primary vaccination in infancy more than 30 years ago. Both individuals did not have any residual antibodies and they did not mount sufficient antibody responses after the booster vaccination. No information was available on their anti-HBs responses after the primary vaccination. Therefore, we cannot rule out the possibility that the NRs never had sufficient antibody responses after primary vaccination, as it has been reported that approx. 5% of vaccinated children do not develop antibodies after primary vaccination (49). By contrast, the individuals with anti-HBs concentrations of <10 IU/ml before the booster, who had received primary vaccination as adults, responded adequately to the booster vaccination. It can be speculated that the rate of successful booster vaccination declines with increasing time since the primary vaccination and that age at the time of primary vaccination also plays a role. Further studies in larger cohorts would be necessary to determine optimal booster schedules, which take into account the age at the time of primary vaccination and the response to this primary series as well as residual antibodies and time since the last vaccination.

      Latent infection with CMV has a substantial impact on the composition of the T cell pool (5053), and an impact of CMV seropositivity on vaccine-induced antibody responses has been suggested (5456), but was not confirmed in other studies (57, 58). CMV serostatus was determined for the participants of the current study, but the sample size was not sufficient to reliably determine the impact of CMV on primary and booster antibody responses in this cohort.

      Because the molecular mechanisms underlying age-related hyporesponsiveness to vaccination remain unclear, whole blood samples for focused gene expression profiling were collected before (d0) and after (d1) receiving the first dose of primary vaccine or booster vaccine. Prior to vaccination, significant age-related changes were found that strongly clustered in a network centered around type I interferons and pro-inflammatory cytokines, and these pathways have been implicated in promoting immunosenescence in older adults (Figure 3) (59). Our observation that pro-inflammatory pathways prevail in the elderly is consistent with a larger study in Canada, where genome-wide RNA expression profiles were compared between young and old adults (30). Importantly, several studies have shown that naïve T cells decrease, while highly differentiated effector and memory T cells accumulate with chronological age (60, 61). This change is not only reflected by an alteration in cell numbers but also reflected by a change in the expression levels of transcripts that are highly and preferentially expressed in T and B lymphocytes (13, 14). In agreement with this view, expression levels of T cell and B cell subset markers (CD3E, IL7R, CD19, BLR1) were altered in old adults compared to younger participants, likely reflecting a shift in the relative abundance of peripheral blood lymphocytes with aging. Moreover, the expression of PTPRCv1 (CD45RA) located on naïve T cells was higher in younger participants, while the expression of PTPRCv2 (CD45RO) located on memory T cells was higher in older participants. This finding is consistent with a progressive increase of memory T cells with chronological age and may therefore reflect age-related changes in immune function.

      A correlation between pre-immunization expression levels and vaccine responsiveness during primary and booster vaccination could only be established for a few genes (Figures 4 and 5). However, during booster vaccination, five of the six genes encompassing a six-gene signature encoded transcripts that were highly and preferentially expressed on T cells and/or B cells (BLR1, CCR7, CD19, CD274, and CTLA4), indicating that specifically during booster vaccination, vaccine responsiveness is largely determined by variances in the representation and/or function of naïve and memory B cell and T cell subsets.

      In contrast to pre-immunization transcriptomic profiles, FCs in gene expression profiles before and after primary vaccination identified a larger 33-gene signature that correlated with different responses to the HBV vaccine (Figure 7), revealing a network dominated by IFN-inducible genes, pro-inflammatory cytokines, inflammasome components, and immune cell subset markers. Type I interferons have been shown to enhance the development of CD4 and CD8 central memory T cells as well as CD4 and CD8 effector memory T cells (62) and to improve B cell function by amplifying the B cell receptor signal (63), providing a plausible explanation for the observed positive association between genes induced by type I interferons and antibody titers. By contrast, a negative association between the induction of regulatory T cell-associated genes (CD3E, IL7R, TGFB1) and antibody titers was found, speculating that in individuals with antibody concentrations of <10,000 IU/l, the accelerated induction/recruitment of regulatory T cells compromises the magnitude and duration of inflammatory responses that are required for optimal antibody production (64). Another prominent group of genes identified in the network were inflammasome components. Reports about the role of these components during vaccination or B cell function are scarce, but it has been documented that the stimulation of NLRP3 by fungal antigens modulated IgM production (65). In addition, NLRP3−/− mice demonstrated a decreased vaccine efficacy as measured by antibody production (66). Together, these data suggest that those signaling networks that change with progressive age, such as inflammation status, contribute to hyporesponsiveness in the elderly during primary vaccination. In contrast to primary vaccination, no correlation between FCs of transcriptomic profiles and vaccine responsiveness could be identified during booster vaccination. This finding is in concordance with the fact that the increase (fold-change) of anti-HBs concentrations after the booster vaccination did not differ between individuals with high and low antibody concentrations at week 4. Our results document that primary differs from booster vaccination in old age, regarding antibody responses as well as at the level of gene signatures.

      Data Availability

      The raw data supporting the conclusions of this manuscript will be made available by the authors upon request.

      Ethics Statement

      The protocol was approved by the ethics committee of the Innsbruck Medical University. All participants gave their written informed consent in accordance with the Declaration of Helsinki. This trial was registered at the EU Clinical Trial Register (EU-CTR) with the EUDRACT-Nr. 2013-002589-38.

      Author Contributions

      BW, BG-L, MH, and TO designed the study. BW, MH, and TB performed experiments. BW, MH, and RP analyzed data. and BW, MH, TO, and BG-L wrote the manuscript. All authors contributed to manuscript revision, read, and approved the submitted version.

      Conflict of Interest Statement

      The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

      Funding. The research leading to these results has received funding from the European Union’s Seventh Framework Programme [FP7/2007-2013] under Grant Agreement No: 280873 ADITEC.

      Supplementary Material

      The Supplementary Material for this article can be found online at /articles/10.3389/fimmu.2018.01035/full#supplementary-material.

      References United Nations. World Population Prospects. (2017). Available from: https://esa.un.org/unpd/wpp (Accessed: July 30, 2017). Gavazzi G Krause KH. Ageing and infection. Lancet Infect Dis (2002) 2:65966.10.1016/S1473-3099(02)00437-112409046 Arnold CR Wolf J Brunner S Herndler-Brandstetter D Grubeck-Loebenstein B. Gain and loss of T cell subsets in old age—age-related reshaping of the T cell repertoire. J Clin Immunol (2011) 31:13746.10.1007/s10875-010-9499-x Scholz JL Diaz A Riley RL Cancro MP Frasca D. A comparative review of aging and B cell function in mice and humans. Curr Opin Immunol (2013) 25:50410.10.1016/j.coi.2013.07.00623932400 Jilkova E Vejvalkova P Stiborova I Skorkovsky J Kral V. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly—results from an observational study. Expert Opin Biol Ther (2009) 9:797803.10.1517/14712590903066711 Cramer JP Dubischar K Eder S Burchard GD Jelinek T Jilma B Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO(R) in elderly subjects: open-label, uncontrolled, multi-center, phase 4 study. Vaccine (2016) 34:457985.10.1016/j.vaccine.2016.07.029 D’Acremont V Herzog C Genton B. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly. J Travel Med (2006) 13:7883.10.1111/j.1708-8305.2006.00001.x16553593 Langley JM Risi G Caldwell M Gilderman L Berwald B Fogarty C Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study. J Infect Dis (2011) 203:172938.10.1093/infdis/jir17221606531 Kaml M Weiskirchner I Keller M Luft T Hoster E Hasford J Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers. Vaccine (2006) 24:680811.10.1016/j.vaccine.2006.06.03716872725 Weinberger B Schirmer M Matteucci GR Siebert U Fuchs D Grubeck-Loebenstein B. Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons. PLoS One (2013) 8:e82967.10.1371/journal.pone.008296724349407 Weinberger B Keller M Fischer KH Stiasny K Neuner C Heinz FX Decreased antibody titers and booster responses in tick-borne encephalitis vaccines aged 50-90 years. Vaccine (2010) 28:35115.10.1016/j.vaccine.2010.03.02420332047 Calabria E Mazza EM Dyar KA Pogliaghi S Bruseghini P Morandi C Aging: a portrait from gene expression profile in blood cells. Aging (Albany NY) (2016) 8:180221.10.18632/aging.10101627545843 Peters MJ Joehanes R Pilling LC Schurmann C Conneely KN Powell J The transcriptional landscape of age in human peripheral blood. Nat Commun (2015) 6:8570.10.1038/ncomms957026490707 Nakamura S Kawai K Takeshita Y Honda M Takamura T Kaneko S Identification of blood biomarkers of aging by transcript profiling of whole blood. Biochem Biophys Res Commun (2012) 418:3138.10.1016/j.bbrc.2012.01.01822266314 European Centre for Disease Prevention and Control. Hepatitis B and C in the EU Neighbourhood: Prevalence, Burden of Disease and Screening Policies. (2010). Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/TER_100914_Hep_B_C%20_EU_neighbourhood.pdf (Accessed: December 1, 2017). Loustaud-Ratti V Jacques J Debette-Gratien M Carrier P. Hepatitis B and elders: an underestimated issue. Hepatol Res (2016) 46:228.10.1111/hepr.1249925651806 Marcus EL Tur-Kaspa R. Viral hepatitis in older adults. J Am Geriatr Soc (1997) 45:75563.10.1111/j.1532-5415.1997.tb01484.x9180674 Goodson JD Taylor PA Campion EW Richter JM Wands J. The clinical course of acute hepatitis in the elderly patient. Arch Intern Med (1982) 142:14858.10.1001/archinte.142.8.14857103629 Wynne HA Cope LH Mutch E Rawlins MD Woodhouse KW James OF. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology (1989) 9:297301.10.1002/hep.18400902222643548 Kondo Y Tsukada K Takeuchi T Mitsui T Iwano K Masuko K High carrier rate after hepatitis B virus infection in the elderly. Hepatology (1993) 18:76874.10.1002/hep.18401804048406349 Sugauchi F Mizokami M Orito E Ohno T Kato H Maki M Hepatitis B virus infection among residents of a nursing home for the elderly: seroepidemiological study and molecular evolutionary analysis. J Med Virol (2000) 62:45662.10.1002/1096-9071(200012)62:4<456::AID-JMV10>3.0.CO;2-311074474 Kim DK Riley LE Harriman KH Hunter P Bridges CB. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older-United States, 2017. MMWR Morb Mortal Wkly Rep (2017) 66:1368.10.15585/mmwr.mm6605e2 Impfplan Österreich. (2017). Available from: https://www.bmgf.gv.at/cms/home/attachments/2/8/1/CH1100/CMS1452867487477/impfplan.pdf (Accessed: November 8, 2017). Ständige Impfkommission. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epid Bull (2017) 34:33380.10.17886/EpiBull-2017-044.1 Calendrier Des Vaccinations et Recommandations Vaccinales 2017. (2017). Available from: https://solidarites-sante.gouv.fr/IMG/pdf/calendrier_vaccinations_2017.pdf (Accessed: November 8, 2017). Programa Nacional De Vacinacao. (2017). Available from: https://www.dgs.pt/directrizes-da-dgs/normas-e-circulares-normativas/norma-n-0162016-de-16122016-pdf.aspx (Accessed: November 8, 2017). Piano Nazionale Prevenzione Vaccinale. (2017). Available from: https://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf (Accessed: November 8, 2017). Statistics Canada. International Travel 2008. Ottawa: Minister of Industry (2009). Report No.:Cat 66-201-X. Overseas Arrivals and Departures, Australia. (2016). Available from: https://www.abs.gov.au/ausstats/abs@.nsf/products/961B6B53B87C130ACA2574030010BD05 (Accessed: January 14, 2016). Joosten SA Goeman JJ Sutherland JS Opmeer L de Boer KG Jacobsen M Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes Immun (2012) 13:7182.10.1038/gene.2011.6421956656 Fourati S Cristescu R Loboda A Talla A Filali A Railkar R Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination. Nat Commun (2016) 7:10369.10.1038/ncomms1036926742691 Roukens AH Soonawala D Joosten SA de Visser AW Jiang X Dirksen K Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study. PLoS One (2011) 6:e27753.10.1371/journal.pone.002775322163273 Denis F Mounier M Hessel L Michel JP Gualde N Dubois F Hepatitis-B vaccination in the elderly. J Infect Dis (1984) 149:1019.10.1093/infdis/149.6.1019 de Rave S Heijtink RA Bakker-Bendik M Boot J Schalm SW. Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers. Vaccine (1994) 12:5324.10.1016/0264-410X(94)90313-18036828 Vermeiren AP Hoebe CJ Dukers-Muijrers NH. High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees. J Clin Virol (2013) 58:2624.10.1016/j.jcv.2013.07.00323895931 Wolters B Junge U Dziuba S Roggendorf M. Immunogenicity of combined hepatitis A and B vaccine in elderly persons. Vaccine (2003) 21:36238.10.1016/S0264-410X(03)00399-212922091 Fisman DN Agrawal D Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis (2002) 35:136875.10.1086/34427112439800 Van Der Meeren O Crasta P Cheuvart B De Ridder M. Characterization of an age-response relationship to GSK’s recombinant hepatitis B vaccine in healthy adults: an integrated analysis. Hum Vaccin Immunother (2015) 11:17269.10.1080/21645515.2015.103975825996260 Williams RE Sena AC Moorman AC Moore ZS Sharapov UM Drobenuic J Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak. Vaccine (2012) 30:314750.10.1016/j.vaccine.2012.02.078 Centers for Disease Control and Prevention (CDC). Hepatitis B FAQs for Health Professionals. (2016). Available from: https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm (Accessed: December 8, 2017). Bauer T Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine (2006) 24:5727.10.1016/j.vaccine.2005.08.05816171909 Van Damme P Leroux-Roels G Suryakiran P Folschweiller N Van Der Meeren O. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine. Hum Vaccin Immunother (2017) 13:97280.10.1080/21645515.2016.1274473 Gara N Abdalla A Rivera E Zhao X Werner JM Liang TJ Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults. Clin Infect Dis (2015) 60:50513.10.1093/cid/ciu86725389254 Beran J Van Der Meeren O Leyssen M D’silva P. Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine. Vaccine (2016) 34:268691.10.1016/j.vaccine.2016.04.03327105563 Bassal R Markovich MP Weil M Shinar E Carmeli Y Dan M Prevalence of anti-hepatitis B surface antibodies among children and adolescents vaccinated in infancy and effect of booster dose administered within a pilot study. Epidemiol Infect (2017) 145:28905.10.1017/S095026881700212628903797 Middleman AB Baker CJ Kozinetz CA Kamili S Nguyen C Hu DJ Duration of protection after infant hepatitis B vaccination series. Pediatrics (2014) 133:e15007.10.1542/peds.2013-2940 Spada E Romano L Tosti ME Zuccaro O Paladini S Chironna M Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study. Clin Microbiol Infect (2014) 20:O6806.10.1111/1469-0691.1259124528380 Leuridan E Van DP. Hepatitis B and the need for a booster dose. Clin Infect Dis (2011) 53:6875.10.1093/cid/cir27021653306 Coates T Wilson R Patrick G Andre F Watson V. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther (2001) 23:392403.10.1016/S0149-2918(01)80044-811318074 Almanzar G Schwaiger S Jenewein B Keller M Herndler-Brandstetter D Wurzner R Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol (2005) 79:367583.10.1128/JVI.79.6.3675-3683.200515731261 Weinberger B Lazuardi L Weiskirchner I Keller M Neuner C Fischer KH Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol (2007) 68:8690.10.1016/j.humimm.2006.10.01917321897 Colonna-Romano G Akbar AN Aquino A Bulati M Candore G Lio D Impact of CMV and EBV seropositivity on CD8 T lymphocytes in an old population from West-Sicily. Exp Gerontol (2007) 42:9951002.10.1016/j.exger.2007.05.00617611062 Pawelec G Derhovanessian E. Role of CMV in immune senescence. Virus Res (2011) 157:1759.10.1016/j.virusres.2010.09.01020869407 Frasca D Blomberg BB. Aging, cytomegalovirus (CMV) and influenza vaccine responses. Hum Vaccin Immunother (2016) 12(3):68290.10.1080/21645515.2015.1105413 Derhovanessian E Maier AB Hahnel K McElhaney JE Slagboom EP Pawelec G. Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly. J Immunol (2014) 193:362431.10.4049/jimmunol.130336125187662 Weinberger B Keller M Grubeck-Loebenstein B. Long-term maintenance of diphtheria-specific antibodies after booster vaccination is hampered by latent infection with cytomegalovirus. Immun Ageing (2017) 14:16.10.1186/s12979-017-0099-y28670328 den Elzen WP Vossen AC Cools HJ Westendorp RG Kroes AC Gussekloo J. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine (2011) 29:486974.10.1016/j.vaccine.2011.03.08621497631 van den Berg SPH Wong A Hendriks M Jacobi RHJ van BD van BJ. Negative effect of age, but not of latent cytomegalovirus infection on the antibody response to a novel influenza vaccine strain in healthy adults. Front Immunol (2018) 9:82.10.3389/fimmu.2018.0008229434600 Panda A Arjona A Sapey E Bai F Fikrig E Montgomery RR Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol (2009) 30:32533.10.1016/j.it.2009.05.004 Weiskopf D Weinberger B Grubeck-Loebenstein B. The aging of the immune system. Transpl Int (2009) 22:104150.10.1111/j.1432-2277.2009.00927.x19624493 Moro-Garcia MA Alonso-Arias R Lopez-Larrea C. Molecular mechanisms involved in the aging of the T-cell immune response. Curr Genomics (2012) 13:589602.10.2174/13892021280375974923730199 Huber JP Farrar JD. Regulation of effector and memory T-cell functions by type I interferon. Immunology (2011) 132:46674.10.1111/j.1365-2567.2011.03412.x21320124 Braun D Caramalho I Demengeot J. IFN-alpha/beta enhances BCR-dependent B cell responses. Int Immunol (2002) 14:4119.10.1093/intimm/14.4.41111934877 Lehtimaki S Lahesmaa R. Regulatory T cells control immune responses through their non-redundant tissue specific features. Front Immunol (2013) 4:294.10.3389/fimmu.2013.0029424069022 Ali MF Dasari H Van Keulen VP Carmona EM. Canonical stimulation of the NLRP3 inflammasome by fungal antigens links innate and adaptive B-lymphocyte responses by modulating IL-1beta and IgM production. Front Immunol (2017) 8:1504.10.3389/fimmu.2017.01504 Davis BK Wen H Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol (2011) 29:70735.10.1146/annurev-immunol-031210-10140521219188

      1http://biit.cs.ut.ee/clustvis/ (Accessed: November 26, 2017).

      2https://string-db.org/ (Accessed: December 5, 2017).

      ‘Oh, my dear Thomas, you haven’t heard the terrible news then?’ she said. ‘I thought you would be sure to have seen it placarded somewhere. Alice went straight to her room, and I haven’t seen her since, though I repeatedly knocked at the door, which she has locked on the inside, and I’m sure it’s most unnatural of her not to let her own mother comfort her. It all happened in a moment: I have always said those great motor-cars shouldn’t be allowed to career about the streets, especially when they are all paved with cobbles as they are at Easton Haven, which are{331} so slippery when it’s wet. He slipped, and it went over him in a moment.’ My thanks were few and awkward, for there still hung to the missive a basting thread, and it was as warm as a nestling bird. I bent low--everybody was emotional in those days--kissed the fragrant thing, thrust it into my bosom, and blushed worse than Camille. "What, the Corner House victim? Is that really a fact?" "My dear child, I don't look upon it in that light at all. The child gave our picturesque friend a certain distinction--'My husband is dead, and this is my only child,' and all that sort of thing. It pays in society." leave them on the steps of a foundling asylum in order to insure [See larger version] Interoffice guff says you're planning definite moves on your own, J. O., and against some opposition. Is the Colonel so poor or so grasping—or what? Albert could not speak, for he felt as if his brains and teeth were rattling about inside his head. The rest of[Pg 188] the family hunched together by the door, the boys gaping idiotically, the girls in tears. "Now you're married." The host was called in, and unlocked a drawer in which they were deposited. The galleyman, with visible reluctance, arrayed himself in the garments, and he was observed to shudder more than once during the investiture of the dead man's apparel. HoME香京julia种子在线播放 ENTER NUMBET 0016www.humsocc.org.cn
      fushipifa.net.cn
      www.jlfyuq.com.cn
      www.iibggm.com.cn
      gfltech.com.cn
      juzix.com.cn
      www.silk-ev.com.cn
      rkchain.com.cn
      www.svns.com.cn
      the20s.com.cn
      处女被大鸡巴操 强奸乱伦小说图片 俄罗斯美女爱爱图 调教强奸学生 亚洲女的穴 夜来香图片大全 美女性强奸电影 手机版色中阁 男性人体艺术素描图 16p成人 欧美性爱360 电影区 亚洲电影 欧美电影 经典三级 偷拍自拍 动漫电影 乱伦电影 变态另类 全部电 类似狠狠鲁的网站 黑吊操白逼图片 韩国黄片种子下载 操逼逼逼逼逼 人妻 小说 p 偷拍10幼女自慰 极品淫水很多 黄色做i爱 日本女人人体电影快播看 大福国小 我爱肏屄美女 mmcrwcom 欧美多人性交图片 肥臀乱伦老头舔阴帝 d09a4343000019c5 西欧人体艺术b xxoo激情短片 未成年人的 插泰国人夭图片 第770弾み1 24p 日本美女性 交动态 eee色播 yantasythunder 操无毛少女屄 亚洲图片你懂的女人 鸡巴插姨娘 特级黄 色大片播 左耳影音先锋 冢本友希全集 日本人体艺术绿色 我爱被舔逼 内射 幼 美阴图 喷水妹子高潮迭起 和后妈 操逼 美女吞鸡巴 鸭个自慰 中国女裸名单 操逼肥臀出水换妻 色站裸体义术 中国行上的漏毛美女叫什么 亚洲妹性交图 欧美美女人裸体人艺照 成人色妹妹直播 WWW_JXCT_COM r日本女人性淫乱 大胆人艺体艺图片 女同接吻av 碰碰哥免费自拍打炮 艳舞写真duppid1 88电影街拍视频 日本自拍做爱qvod 实拍美女性爱组图 少女高清av 浙江真实乱伦迅雷 台湾luanlunxiaoshuo 洛克王国宠物排行榜 皇瑟电影yy频道大全 红孩儿连连看 阴毛摄影 大胆美女写真人体艺术摄影 和风骚三个媳妇在家做爱 性爱办公室高清 18p2p木耳 大波撸影音 大鸡巴插嫩穴小说 一剧不超两个黑人 阿姨诱惑我快播 幼香阁千叶县小学生 少女妇女被狗强奸 曰人体妹妹 十二岁性感幼女 超级乱伦qvod 97爱蜜桃ccc336 日本淫妇阴液 av海量资源999 凤凰影视成仁 辰溪四中艳照门照片 先锋模特裸体展示影片 成人片免费看 自拍百度云 肥白老妇女 女爱人体图片 妈妈一女穴 星野美夏 日本少女dachidu 妹子私处人体图片 yinmindahuitang 舔无毛逼影片快播 田莹疑的裸体照片 三级电影影音先锋02222 妻子被外国老头操 观月雏乃泥鳅 韩国成人偷拍自拍图片 强奸5一9岁幼女小说 汤姆影院av图片 妹妹人艺体图 美女大驱 和女友做爱图片自拍p 绫川まどか在线先锋 那么嫩的逼很少见了 小女孩做爱 处女好逼连连看图图 性感美女在家做爱 近距离抽插骚逼逼 黑屌肏金毛屄 日韩av美少女 看喝尿尿小姐日逼色色色网图片 欧美肛交新视频 美女吃逼逼 av30线上免费 伊人在线三级经典 新视觉影院t6090影院 最新淫色电影网址 天龙影院远古手机版 搞老太影院 插进美女的大屁股里 私人影院加盟费用 www258dd 求一部电影里面有一个二猛哥 深肛交 日本萌妹子人体艺术写真图片 插入屄眼 美女的木奶 中文字幕黄色网址影视先锋 九号女神裸 和骚人妻偷情 和潘晓婷做爱 国模大尺度蜜桃 欧美大逼50p 西西人体成人 李宗瑞继母做爱原图物处理 nianhuawang 男鸡巴的视屏 � 97免费色伦电影 好色网成人 大姨子先锋 淫荡巨乳美女教师妈妈 性nuexiaoshuo WWW36YYYCOM 长春继续给力进屋就操小女儿套干破内射对白淫荡 农夫激情社区 日韩无码bt 欧美美女手掰嫩穴图片 日本援交偷拍自拍 入侵者日本在线播放 亚洲白虎偷拍自拍 常州高见泽日屄 寂寞少妇自卫视频 人体露逼图片 多毛外国老太 变态乱轮手机在线 淫荡妈妈和儿子操逼 伦理片大奶少女 看片神器最新登入地址sqvheqi345com账号群 麻美学姐无头 圣诞老人射小妞和强奸小妞动话片 亚洲AV女老师 先锋影音欧美成人资源 33344iucoom zV天堂电影网 宾馆美女打炮视频 色五月丁香五月magnet 嫂子淫乱小说 张歆艺的老公 吃奶男人视频在线播放 欧美色图男女乱伦 avtt2014ccvom 性插色欲香影院 青青草撸死你青青草 99热久久第一时间 激情套图卡通动漫 幼女裸聊做爱口交 日本女人被强奸乱伦 草榴社区快播 2kkk正在播放兽骑 啊不要人家小穴都湿了 www猎奇影视 A片www245vvcomwwwchnrwhmhzcn 搜索宜春院av wwwsee78co 逼奶鸡巴插 好吊日AV在线视频19gancom 熟女伦乱图片小说 日本免费av无码片在线开苞 鲁大妈撸到爆 裸聊官网 德国熟女xxx 新不夜城论坛首页手机 女虐男网址 男女做爱视频华为网盘 激情午夜天亚洲色图 内裤哥mangent 吉沢明歩制服丝袜WWWHHH710COM 屌逼在线试看 人体艺体阿娇艳照 推荐一个可以免费看片的网站如果被QQ拦截请复制链接在其它浏览器打开xxxyyy5comintr2a2cb551573a2b2e 欧美360精品粉红鲍鱼 教师调教第一页 聚美屋精品图 中韩淫乱群交 俄罗斯撸撸片 把鸡巴插进小姨子的阴道 干干AV成人网 aolasoohpnbcn www84ytom 高清大量潮喷www27dyycom 宝贝开心成人 freefronvideos人母 嫩穴成人网gggg29com 逼着舅妈给我口交肛交彩漫画 欧美色色aV88wwwgangguanscom 老太太操逼自拍视频 777亚洲手机在线播放 有没有夫妻3p小说 色列漫画淫女 午间色站导航 欧美成人处女色大图 童颜巨乳亚洲综合 桃色性欲草 色眯眯射逼 无码中文字幕塞外青楼这是一个 狂日美女老师人妻 爱碰网官网 亚洲图片雅蠛蝶 快播35怎么搜片 2000XXXX电影 新谷露性家庭影院 深深候dvd播放 幼齿用英语怎么说 不雅伦理无需播放器 国外淫荡图片 国外网站幼幼嫩网址 成年人就去色色视频快播 我鲁日日鲁老老老我爱 caoshaonvbi 人体艺术avav 性感性色导航 韩国黄色哥来嫖网站 成人网站美逼 淫荡熟妇自拍 欧美色惰图片 北京空姐透明照 狼堡免费av视频 www776eom 亚洲无码av欧美天堂网男人天堂 欧美激情爆操 a片kk266co 色尼姑成人极速在线视频 国语家庭系列 蒋雯雯 越南伦理 色CC伦理影院手机版 99jbbcom 大鸡巴舅妈 国产偷拍自拍淫荡对话视频 少妇春梦射精 开心激动网 自拍偷牌成人 色桃隐 撸狗网性交视频 淫荡的三位老师 伦理电影wwwqiuxia6commqiuxia6com 怡春院分站 丝袜超短裙露脸迅雷下载 色制服电影院 97超碰好吊色男人 yy6080理论在线宅男日韩福利大全 大嫂丝袜 500人群交手机在线 5sav 偷拍熟女吧 口述我和妹妹的欲望 50p电脑版 wwwavtttcon 3p3com 伦理无码片在线看 欧美成人电影图片岛国性爱伦理电影 先锋影音AV成人欧美 我爱好色 淫电影网 WWW19MMCOM 玛丽罗斯3d同人动画h在线看 动漫女孩裸体 超级丝袜美腿乱伦 1919gogo欣赏 大色逼淫色 www就是撸 激情文学网好骚 A级黄片免费 xedd5com 国内的b是黑的 快播美国成年人片黄 av高跟丝袜视频 上原保奈美巨乳女教师在线观看 校园春色都市激情fefegancom 偷窥自拍XXOO 搜索看马操美女 人本女优视频 日日吧淫淫 人妻巨乳影院 美国女子性爱学校 大肥屁股重口味 啪啪啪啊啊啊不要 操碰 japanfreevideoshome国产 亚州淫荡老熟女人体 伦奸毛片免费在线看 天天影视se 樱桃做爱视频 亚卅av在线视频 x奸小说下载 亚洲色图图片在线 217av天堂网 东方在线撸撸-百度 幼幼丝袜集 灰姑娘的姐姐 青青草在线视频观看对华 86papa路con 亚洲1AV 综合图片2区亚洲 美国美女大逼电影 010插插av成人网站 www色comwww821kxwcom 播乐子成人网免费视频在线观看 大炮撸在线影院 ,www4KkKcom 野花鲁最近30部 wwwCC213wapwww2233ww2download 三客优最新地址 母亲让儿子爽的无码视频 全国黄色片子 欧美色图美国十次 超碰在线直播 性感妖娆操 亚洲肉感熟女色图 a片A毛片管看视频 8vaa褋芯屑 333kk 川岛和津实视频 在线母子乱伦对白 妹妹肥逼五月 亚洲美女自拍 老婆在我面前小说 韩国空姐堪比情趣内衣 干小姐综合 淫妻色五月 添骚穴 WM62COM 23456影视播放器 成人午夜剧场 尼姑福利网 AV区亚洲AV欧美AV512qucomwwwc5508com 经典欧美骚妇 震动棒露出 日韩丝袜美臀巨乳在线 av无限吧看 就去干少妇 色艺无间正面是哪集 校园春色我和老师做爱 漫画夜色 天海丽白色吊带 黄色淫荡性虐小说 午夜高清播放器 文20岁女性荫道口图片 热国产热无码热有码 2015小明发布看看算你色 百度云播影视 美女肏屄屄乱轮小说 家族舔阴AV影片 邪恶在线av有码 父女之交 关于处女破处的三级片 极品护士91在线 欧美虐待女人视频的网站 享受老太太的丝袜 aaazhibuo 8dfvodcom成人 真实自拍足交 群交男女猛插逼 妓女爱爱动态 lin35com是什么网站 abp159 亚洲色图偷拍自拍乱伦熟女抠逼自慰 朝国三级篇 淫三国幻想 免费的av小电影网站 日本阿v视频免费按摩师 av750c0m 黄色片操一下 巨乳少女车震在线观看 操逼 免费 囗述情感一乱伦岳母和女婿 WWW_FAMITSU_COM 偷拍中国少妇在公车被操视频 花也真衣论理电影 大鸡鸡插p洞 新片欧美十八岁美少 进击的巨人神thunderftp 西方美女15p 深圳哪里易找到老女人玩视频 在线成人有声小说 365rrr 女尿图片 我和淫荡的小姨做爱 � 做爱技术体照 淫妇性爱 大学生私拍b 第四射狠狠射小说 色中色成人av社区 和小姨子乱伦肛交 wwwppp62com 俄罗斯巨乳人体艺术 骚逼阿娇 汤芳人体图片大胆 大胆人体艺术bb私处 性感大胸骚货 哪个网站幼女的片多 日本美女本子把 色 五月天 婷婷 快播 美女 美穴艺术 色百合电影导航 大鸡巴用力 孙悟空操美少女战士 狠狠撸美女手掰穴图片 古代女子与兽类交 沙耶香套图 激情成人网区 暴风影音av播放 动漫女孩怎么插第3个 mmmpp44 黑木麻衣无码ed2k 淫荡学姐少妇 乱伦操少女屄 高中性爱故事 骚妹妹爱爱图网 韩国模特剪长发 大鸡巴把我逼日了 中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片 大胆女人下体艺术图片 789sss 影音先锋在线国内情侣野外性事自拍普通话对白 群撸图库 闪现君打阿乐 ady 小说 插入表妹嫩穴小说 推荐成人资源 网络播放器 成人台 149大胆人体艺术 大屌图片 骚美女成人av 春暖花开春色性吧 女亭婷五月 我上了同桌的姐姐 恋夜秀场主播自慰视频 yzppp 屄茎 操屄女图 美女鲍鱼大特写 淫乱的日本人妻山口玲子 偷拍射精图 性感美女人体艺木图片 种马小说完本 免费电影院 骑士福利导航导航网站 骚老婆足交 国产性爱一级电影 欧美免费成人花花性都 欧美大肥妞性爱视频 家庭乱伦网站快播 偷拍自拍国产毛片 金发美女也用大吊来开包 缔D杏那 yentiyishu人体艺术ytys WWWUUKKMCOM 女人露奶 � 苍井空露逼 老荡妇高跟丝袜足交 偷偷和女友的朋友做爱迅雷 做爱七十二尺 朱丹人体合成 麻腾由纪妃 帅哥撸播种子图 鸡巴插逼动态图片 羙国十次啦中文 WWW137AVCOM 神斗片欧美版华语 有气质女人人休艺术 由美老师放屁电影 欧美女人肉肏图片 白虎种子快播 国产自拍90后女孩 美女在床上疯狂嫩b 饭岛爱最后之作 幼幼强奸摸奶 色97成人动漫 两性性爱打鸡巴插逼 新视觉影院4080青苹果影院 嗯好爽插死我了 阴口艺术照 李宗瑞电影qvod38 爆操舅母 亚洲色图七七影院 被大鸡巴操菊花 怡红院肿么了 成人极品影院删除 欧美性爱大图色图强奸乱 欧美女子与狗随便性交 苍井空的bt种子无码 熟女乱伦长篇小说 大色虫 兽交幼女影音先锋播放 44aad be0ca93900121f9b 先锋天耗ばさ无码 欧毛毛女三级黄色片图 干女人黑木耳照 日本美女少妇嫩逼人体艺术 sesechangchang 色屄屄网 久久撸app下载 色图色噜 美女鸡巴大奶 好吊日在线视频在线观看 透明丝袜脚偷拍自拍 中山怡红院菜单 wcwwwcom下载 骑嫂子 亚洲大色妣 成人故事365ahnet 丝袜家庭教mp4 幼交肛交 妹妹撸撸大妈 日本毛爽 caoprom超碰在email 关于中国古代偷窥的黄片 第一会所老熟女下载 wwwhuangsecome 狼人干综合新地址HD播放 变态儿子强奸乱伦图 强奸电影名字 2wwwer37com 日本毛片基地一亚洲AVmzddcxcn 暗黑圣经仙桃影院 37tpcocn 持月真由xfplay 好吊日在线视频三级网 我爱背入李丽珍 电影师傅床戏在线观看 96插妹妹sexsex88com 豪放家庭在线播放 桃花宝典极夜著豆瓜网 安卓系统播放神器 美美网丝袜诱惑 人人干全免费视频xulawyercn av无插件一本道 全国色五月 操逼电影小说网 good在线wwwyuyuelvcom www18avmmd 撸波波影视无插件 伊人幼女成人电影 会看射的图片 小明插看看 全裸美女扒开粉嫩b 国人自拍性交网站 萝莉白丝足交本子 七草ちとせ巨乳视频 摇摇晃晃的成人电影 兰桂坊成社人区小说www68kqcom 舔阴论坛 久撸客一撸客色国内外成人激情在线 明星门 欧美大胆嫩肉穴爽大片 www牛逼插 性吧星云 少妇性奴的屁眼 人体艺术大胆mscbaidu1imgcn 最新久久色色成人版 l女同在线 小泽玛利亚高潮图片搜索 女性裸b图 肛交bt种子 最热门有声小说 人间添春色 春色猜谜字 樱井莉亚钢管舞视频 小泽玛利亚直美6p 能用的h网 还能看的h网 bl动漫h网 开心五月激 东京热401 男色女色第四色酒色网 怎么下载黄色小说 黄色小说小栽 和谐图城 乐乐影院 色哥导航 特色导航 依依社区 爱窝窝在线 色狼谷成人 91porn 包要你射电影 色色3A丝袜 丝袜妹妹淫网 爱色导航(荐) 好男人激情影院 坏哥哥 第七色 色久久 人格分裂 急先锋 撸撸射中文网 第一会所综合社区 91影院老师机 东方成人激情 怼莪影院吹潮 老鸭窝伊人无码不卡无码一本道 av女柳晶电影 91天生爱风流作品 深爱激情小说私房婷婷网 擼奶av 567pao 里番3d一家人野外 上原在线电影 水岛津实透明丝袜 1314酒色 网旧网俺也去 0855影院 在线无码私人影院 搜索 国产自拍 神马dy888午夜伦理达达兔 农民工黄晓婷 日韩裸体黑丝御姐 屈臣氏的燕窝面膜怎么样つぼみ晶エリーの早漏チ○ポ强化合宿 老熟女人性视频 影音先锋 三上悠亚ol 妹妹影院福利片 hhhhhhhhsxo 午夜天堂热的国产 强奸剧场 全裸香蕉视频无码 亚欧伦理视频 秋霞为什么给封了 日本在线视频空天使 日韩成人aⅴ在线 日本日屌日屄导航视频 在线福利视频 日本推油无码av magnet 在线免费视频 樱井梨吮东 日本一本道在线无码DVD 日本性感诱惑美女做爱阴道流水视频 日本一级av 汤姆avtom在线视频 台湾佬中文娱乐线20 阿v播播下载 橙色影院 奴隶少女护士cg视频 汤姆在线影院无码 偷拍宾馆 业面紧急生级访问 色和尚有线 厕所偷拍一族 av女l 公交色狼优酷视频 裸体视频AV 人与兽肉肉网 董美香ol 花井美纱链接 magnet 西瓜影音 亚洲 自拍 日韩女优欧美激情偷拍自拍 亚洲成年人免费视频 荷兰免费成人电影 深喉呕吐XXⅩX 操石榴在线视频 天天色成人免费视频 314hu四虎 涩久免费视频在线观看 成人电影迅雷下载 能看见整个奶子的香蕉影院 水菜丽百度影音 gwaz079百度云 噜死你们资源站 主播走光视频合集迅雷下载 thumbzilla jappen 精品Av 古川伊织star598在线 假面女皇vip在线视频播放 国产自拍迷情校园 啪啪啪公寓漫画 日本阿AV 黄色手机电影 欧美在线Av影院 华裔电击女神91在线 亚洲欧美专区 1日本1000部免费视频 开放90后 波多野结衣 东方 影院av 页面升级紧急访问每天正常更新 4438Xchengeren 老炮色 a k福利电影 色欲影视色天天视频 高老庄aV 259LUXU-683 magnet 手机在线电影 国产区 欧美激情人人操网 国产 偷拍 直播 日韩 国内外激情在线视频网给 站长统计一本道人妻 光棍影院被封 紫竹铃取汁 ftp 狂插空姐嫩 xfplay 丈夫面前 穿靴子伪街 XXOO视频在线免费 大香蕉道久在线播放 电棒漏电嗨过头 充气娃能看下毛和洞吗 夫妻牲交 福利云点墦 yukun瑟妃 疯狂交换女友 国产自拍26页 腐女资源 百度云 日本DVD高清无码视频 偷拍,自拍AV伦理电影 A片小视频福利站。 大奶肥婆自拍偷拍图片 交配伊甸园 超碰在线视频自拍偷拍国产 小热巴91大神 rctd 045 类似于A片 超美大奶大学生美女直播被男友操 男友问 你的衣服怎么脱掉的 亚洲女与黑人群交视频一 在线黄涩 木内美保步兵番号 鸡巴插入欧美美女的b舒服 激情在线国产自拍日韩欧美 国语福利小视频在线观看 作爱小视颍 潮喷合集丝袜无码mp4 做爱的无码高清视频 牛牛精品 伊aⅤ在线观看 savk12 哥哥搞在线播放 在线电一本道影 一级谍片 250pp亚洲情艺中心,88 欧美一本道九色在线一 wwwseavbacom色av吧 cos美女在线 欧美17,18ⅹⅹⅹ视频 自拍嫩逼 小电影在线观看网站 筱田优 贼 水电工 5358x视频 日本69式视频有码 b雪福利导航 韩国女主播19tvclub在线 操逼清晰视频 丝袜美女国产视频网址导航 水菜丽颜射房间 台湾妹中文娱乐网 风吟岛视频 口交 伦理 日本熟妇色五十路免费视频 A级片互舔 川村真矢Av在线观看 亚洲日韩av 色和尚国产自拍 sea8 mp4 aV天堂2018手机在线 免费版国产偷拍a在线播放 狠狠 婷婷 丁香 小视频福利在线观看平台 思妍白衣小仙女被邻居强上 萝莉自拍有水 4484新视觉 永久发布页 977成人影视在线观看 小清新影院在线观 小鸟酱后丝后入百度云 旋风魅影四级 香蕉影院小黄片免费看 性爱直播磁力链接 小骚逼第一色影院 性交流的视频 小雪小视频bd 小视频TV禁看视频 迷奸AV在线看 nba直播 任你在干线 汤姆影院在线视频国产 624u在线播放 成人 一级a做爰片就在线看狐狸视频 小香蕉AV视频 www182、com 腿模简小育 学生做爱视频 秘密搜查官 快播 成人福利网午夜 一级黄色夫妻录像片 直接看的gav久久播放器 国产自拍400首页 sm老爹影院 谁知道隔壁老王网址在线 综合网 123西瓜影音 米奇丁香 人人澡人人漠大学生 色久悠 夜色视频你今天寂寞了吗? 菲菲影视城美国 被抄的影院 变态另类 欧美 成人 国产偷拍自拍在线小说 不用下载安装就能看的吃男人鸡巴视频 插屄视频 大贯杏里播放 wwwhhh50 233若菜奈央 伦理片天海翼秘密搜查官 大香蕉在线万色屋视频 那种漫画小说你懂的 祥仔电影合集一区 那里可以看澳门皇冠酒店a片 色自啪 亚洲aV电影天堂 谷露影院ar toupaizaixian sexbj。com 毕业生 zaixian mianfei 朝桐光视频 成人短视频在线直接观看 陈美霖 沈阳音乐学院 导航女 www26yjjcom 1大尺度视频 开平虐女视频 菅野雪松协和影视在线视频 华人play在线视频bbb 鸡吧操屄视频 多啪啪免费视频 悠草影院 金兰策划网 (969) 橘佑金短视频 国内一极刺激自拍片 日本制服番号大全magnet 成人动漫母系 电脑怎么清理内存 黄色福利1000 dy88午夜 偷拍中学生洗澡磁力链接 花椒相机福利美女视频 站长推荐磁力下载 mp4 三洞轮流插视频 玉兔miki热舞视频 夜生活小视频 爆乳人妖小视频 国内网红主播自拍福利迅雷下载 不用app的裸裸体美女操逼视频 变态SM影片在线观看 草溜影院元气吧 - 百度 - 百度 波推全套视频 国产双飞集合ftp 日本在线AV网 笔国毛片 神马影院女主播是我的邻居 影音资源 激情乱伦电影 799pao 亚洲第一色第一影院 av视频大香蕉 老梁故事汇希斯莱杰 水中人体磁力链接 下载 大香蕉黄片免费看 济南谭崔 避开屏蔽的岛a片 草破福利 要看大鸡巴操小骚逼的人的视频 黑丝少妇影音先锋 欧美巨乳熟女磁力链接 美国黄网站色大全 伦蕉在线久播 极品女厕沟 激情五月bd韩国电影 混血美女自摸和男友激情啪啪自拍诱人呻吟福利视频 人人摸人人妻做人人看 44kknn 娸娸原网 伊人欧美 恋夜影院视频列表安卓青青 57k影院 如果电话亭 avi 插爆骚女精品自拍 青青草在线免费视频1769TV 令人惹火的邻家美眉 影音先锋 真人妹子被捅动态图 男人女人做完爱视频15 表姐合租两人共处一室晚上她竟爬上了我的床 性爱教学视频 北条麻妃bd在线播放版 国产老师和师生 magnet wwwcctv1024 女神自慰 ftp 女同性恋做激情视频 欧美大胆露阴视频 欧美无码影视 好女色在线观看 后入肥臀18p 百度影视屏福利 厕所超碰视频 强奸mp magnet 欧美妹aⅴ免费线上看 2016年妞干网视频 5手机在线福利 超在线最视频 800av:cOm magnet 欧美性爱免播放器在线播放 91大款肥汤的性感美乳90后邻家美眉趴着窗台后入啪啪 秋霞日本毛片网站 cheng ren 在线视频 上原亚衣肛门无码解禁影音先锋 美脚家庭教师在线播放 尤酷伦理片 熟女性生活视频在线观看 欧美av在线播放喷潮 194avav 凤凰AV成人 - 百度 kbb9999 AV片AV在线AV无码 爱爱视频高清免费观看 黄色男女操b视频 观看 18AV清纯视频在线播放平台 成人性爱视频久久操 女性真人生殖系统双性人视频 下身插入b射精视频 明星潜规测视频 mp4 免賛a片直播绪 国内 自己 偷拍 在线 国内真实偷拍 手机在线 国产主播户外勾在线 三桥杏奈高清无码迅雷下载 2五福电影院凸凹频频 男主拿鱼打女主,高宝宝 色哥午夜影院 川村まや痴汉 草溜影院费全过程免费 淫小弟影院在线视频 laohantuiche 啪啪啪喷潮XXOO视频 青娱乐成人国产 蓝沢润 一本道 亚洲青涩中文欧美 神马影院线理论 米娅卡莉法的av 在线福利65535 欧美粉色在线 欧美性受群交视频1在线播放 极品喷奶熟妇在线播放 变态另类无码福利影院92 天津小姐被偷拍 磁力下载 台湾三级电髟全部 丝袜美腿偷拍自拍 偷拍女生性行为图 妻子的乱伦 白虎少妇 肏婶骚屄 外国大妈会阴照片 美少女操屄图片 妹妹自慰11p 操老熟女的b 361美女人体 360电影院樱桃 爱色妹妹亚洲色图 性交卖淫姿势高清图片一级 欧美一黑对二白 大色网无毛一线天 射小妹网站 寂寞穴 西西人体模特苍井空 操的大白逼吧 骚穴让我操 拉好友干女朋友3p